CUMBERLAND PHARMACEUTICALS INC reports

Company location: Nashville,, TN
Fiscal year end: 31 December

CUMBERLAND PHARMACEUTICALS INC has filed 1,032 SEC EDGAR filings since 02 May 2002

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 126-150 of 959 matching filings.

Per page

25

Current page

6

4

FORM 4

Filing date: 05 Nov 2024
Reporting date: 01 Oct 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Nov 2024
Reporting date: 01 Oct 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-33637

8-K

Filing date: 04 Nov 2024
Reporting date: 04 Nov 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 03 Oct 2024
Reporting date: 03 Sep 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Oct 2024
Reporting date: 03 Sep 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Oct 2024
Reporting date: 03 Sep 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Oct 2024
Reporting date: 03 Sep 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 05 Sep 2024
Reporting date: 01 Aug 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 04 Sep 2024
Reporting date: 01 Aug 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 04 Sep 2024
Reporting date: 01 Aug 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 04 Sep 2024
Reporting date: 01 Aug 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 04 Sep 2024
Reporting date: 01 Aug 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-33637

10-Q

Filing date: 09 Aug 2024
Reporting date: 30 Jun 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-33637

8-K

Filing date: 06 Aug 2024
Reporting date: 06 Aug 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Aug 2024
Reporting date: 01 Jul 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Aug 2024
Reporting date: 01 Jul 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Aug 2024
Reporting date: 01 Jul 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Aug 2024
Reporting date: 01 Jul 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jul 2024
Reporting date: 13 Jun 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jul 2024
Reporting date: 13 Jun 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jul 2024
Reporting date: 13 Jun 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jul 2024
Reporting date: 13 Jun 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-33637

10-Q

Filing date: 10 May 2024
Reporting date: 31 Mar 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-33637

8-K

Filing date: 07 May 2024
Reporting date: 07 May 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-33637

8-K

Filing date: 29 Apr 2024
Reporting date: 29 Apr 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .